BioLASCO Taiwan Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 59.81 million compared to TWD 65.25 million a year ago. Net income was TWD 14.07 million compared to TWD 13.52 million a year ago. Basic earnings per share from continuing operations was TWD 0.55 compared to TWD 0.53 a year ago. Diluted earnings per share from continuing operations was TWD 0.55 compared to TWD 0.53 a year ago. For the nine months, sales was TWD 169.01 million compared to TWD 214.35 million a year ago. Net income was TWD 31.8 million compared to TWD 42.5 million a year ago. Basic earnings per share from continuing operations was TWD 1.24 compared to TWD 1.66 a year ago. Diluted earnings per share from continuing operations was TWD 1.24 compared to TWD 1.66 a year ago.